Cabaletta Bio, Inc Added to NASDAQ Biotechnology Index.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
12.77 USD | +3.07% | +21.85% | -43.74% |
Mar. 22 | HC Wainwright Adjusts Cabaletta Bio's Price Target to $30 From $25, Maintains Buy Rating | MT |
Mar. 21 | Cabaletta Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-43.74% | 598M | |
+8.90% | 105B | |
-1.13% | 104B | |
+5.79% | 22.94B | |
-12.36% | 22.34B | |
-7.01% | 19.25B | |
-37.08% | 17.08B | |
-9.04% | 16.96B | |
+7.83% | 14.16B | |
+38.71% | 12.63B |
- Stock Market
- Equities
- CABA Stock
- News Cabaletta Bio, Inc.
- Cabaletta Bio, Inc.(NasdaqGS: CABA) added to NASDAQ Biotechnology Index